Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 211

1.

PIK3CA activating mutations: a discordant role in early versus advanced hormone-dependent estrogen receptor–positive breast cancer?

Mayer IA, Arteaga CL.

J Clin Oncol. 2014 Sep 20;32(27):2932-4. No abstract available.

PMID:
25513479
[PubMed - in process]
2.

Kinome wide functional screen identifies role of Polo-like kinase 1 (PLK1) in hormone-independent, ER-positive breast cancer.

Bhola N, Jansen VM, Bafna S, Giltnane JM, Balko JM, Estrada MV, Meszoely I, Mayer I, Abramson V, Ye F, Sanders M, Dugger TC, Van Allen E, Arteaga CL.

Cancer Res. 2014 Dec 5. pii: canres.2475.2014. [Epub ahead of print]

PMID:
25480943
[PubMed - as supplied by publisher]
3.

Molecular Heterogeneity of Triple Negative Breast Cancer.

Abramson VG, Mayer IA.

Curr Breast Cancer Rep. 2014 Sep 1;6(3):154-158.

PMID:
25419441
[PubMed]
4.

LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.

Schwarz LJ, Fox EM, Balko JM, Garrett JT, Kuba MG, Estrada MV, González-Angulo AM, Mills GB, Red-Brewer M, Mayer IA, Abramson V, Rizzo M, Kelley MC, Meszoely IM, Arteaga CL.

J Clin Invest. 2014 Dec 1;124(12):5490-502. doi: 10.1172/JCI72573. Epub 2014 Nov 17.

PMID:
25401474
[PubMed - in process]
5.

Multiparametric Magnetic Resonance Imaging for Predicting Pathological Response After the First Cycle of Neoadjuvant Chemotherapy in Breast Cancer.

Li X, Abramson RG, Arlinghaus LR, Kang H, Chakravarthy AB, Abramson VG, Farley J, Mayer IA, Kelley MC, Meszoely IM, Means-Powell J, Grau AM, Sanders M, Yankeelov TE.

Invest Radiol. 2014 Oct 30. [Epub ahead of print]

PMID:
25360603
[PubMed - as supplied by publisher]
6.

Transcranial Direct Current Stimulation Effects on Single and Paired Flash Visual Evoked Potentials.

Strigaro G, Mayer I, Chen JC, Cantello R, Rothwell JC.

Clin EEG Neurosci. 2014 Sep 23. pii: 1550059414539481. [Epub ahead of print]

PMID:
25253432
[PubMed - as supplied by publisher]
7.

Sympathetic nervous system alterations with HER2+ antagonism: an early marker of cardiac dysfunction with breast cancer treatment?

Lenneman CG, Abdallah WM, Smith HM, Abramson V, Mayer IA, Silverstein C, Silverstein C, Means-Powell J, Paranjape SY, Lenihan D, Sawyer DB, Raj SR.

Ecancermedicalscience. 2014 Jul 17;8:446. doi: 10.3332/ecancer.2014.446. eCollection 2014.

PMID:
25114718
[PubMed]
Free PMC Article
8.

Severe Hypercholesterolemia: A Unique Presentation of Non-Hodgkin's Lymphoma in a Patient with Neurofibromatosis Type 1.

Chudy-Onwugaje K, Anyadike N, Tsirlin Y, Mayer I, Rahmani R.

Case Rep Gastrointest Med. 2014;2014:579352. doi: 10.1155/2014/579352. Epub 2014 Jul 1.

PMID:
25093126
[PubMed]
Free PMC Article
9.

PIK3CA activating mutations: a discordant role in early versus advanced hormone-dependent estrogen receptor–positive breast cancer?

Mayer IA, Arteaga CL.

J Clin Oncol. 2014 Sep 20;32(27):2932-4. No abstract available.

PMID:
25071103
[PubMed - in process]
10.

Subtyping of triple-negative breast cancer.

Mayer IA.

Clin Adv Hematol Oncol. 2013 Nov;11(11):731-2. No abstract available.

PMID:
24896546
[PubMed - in process]
11.

Neurophysiology in Huntington's disease: an update.

Mayer IM, Orth M.

Neurodegener Dis Manag. 2014;4(2):155-64. doi: 10.2217/nmt.14.1.

PMID:
24832033
[PubMed - in process]
12.

Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel.

Johnson DB, Dahlman KH, Knol J, Gilbert J, Puzanov I, Means-Powell J, Balko JM, Lovly CM, Murphy BA, Goff LW, Abramson VG, Crispens MA, Mayer IA, Berlin JD, Horn L, Keedy VL, Reddy NM, Arteaga CL, Sosman JA, Pao W.

Oncologist. 2014 Jun;19(6):616-22. doi: 10.1634/theoncologist.2014-0011. Epub 2014 May 5.

PMID:
24797823
[PubMed - in process]
Free PMC Article
13.

Value of twelfth hour bilirubin level in predicting significant hyperbilirubinemia in preterm infants.

Mayer I, Gursoy T, Hayran M, Ercin S, Ovali F.

J Clin Med Res. 2014 Jun;6(3):190-6. doi: 10.14740/jocmr1639w. Epub 2014 Mar 31.

PMID:
24734145
[PubMed]
Free PMC Article
14.

Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling.

Abramson VG, Cooper Lloyd M, Ballinger T, Sanders ME, Du L, Lai D, Su Z, Mayer I, Levy M, LaFrance DR, Vnencak-Jones CL, Shyr Y, Dahlman KB, Pao W, Arteaga CL.

Breast Cancer Res Treat. 2014 Jun;145(2):389-99. doi: 10.1007/s10549-014-2945-3. Epub 2014 Apr 11.

PMID:
24722917
[PubMed - in process]
15.

Breast cancer version 3.2014.

Gradishar WJ, Anderson BO, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Marcom PK, Mayer IA, McCormick B, Miller RS, Pegram M, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith ML, Soliman H, Somlo G, Ward JH, Wolff AC, Zellars R, Shead DA, Kumar R; National Comprehensive Cancer Network Breast Cancer Panel.

J Natl Compr Canc Netw. 2014 Apr;12(4):542-90.

PMID:
24717572
[PubMed - indexed for MEDLINE]
16.

Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.

Mayer IA, Abramson VG, Isakoff SJ, Forero A, Balko JM, Kuba MG, Sanders ME, Yap JT, Van den Abbeele AD, Li Y, Cantley LC, Winer E, Arteaga CL.

J Clin Oncol. 2014 Apr 20;32(12):1202-9. doi: 10.1200/JCO.2013.54.0518. Epub 2014 Mar 24.

PMID:
24663045
[PubMed - indexed for MEDLINE]
17.

Covalent bonding: the role of exchange effects.

Mayer I.

J Phys Chem A. 2014 Apr 3;118(13):2543-6. doi: 10.1021/jp501232u. Epub 2014 Mar 20.

PMID:
24625298
[PubMed]
18.

New strategies for triple-negative breast cancer--deciphering the heterogeneity.

Mayer IA, Abramson VG, Lehmann BD, Pietenpol JA.

Clin Cancer Res. 2014 Feb 15;20(4):782-90. doi: 10.1158/1078-0432.CCR-13-0583. Review.

PMID:
24536073
[PubMed - indexed for MEDLINE]
19.

Gefitinib and celecoxib in advanced metastatic gastrointestinal tumors: a pilot feasibility study.

Yamaguchi NH, Mayer IA, Malzyner A, de Andrade CJ, Murad AM, Del Giglio A, Alves V.

J Gastrointest Oncol. 2014 Feb;5(1):57-66. doi: 10.3978/j.issn.2078-6891.2013.056.

PMID:
24490043
[PubMed]
Free PMC Article
20.

Lamella settlers for storm water treatment - performance and design recommendations.

Fuchs S, Mayer I, Haller B, Roth H.

Water Sci Technol. 2014;69(2):278-85. doi: 10.2166/wst.2013.698.

PMID:
24473295
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk